查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2008261

十二指腸內視鏡市場：按產品類型、分銷管道、最終用戶和應用分類的全球市場預測，2026-2032年

Duodenoscopes Market by Product Type, Distribution Channel, End User, Application - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，十二指腸內視鏡市場價值將達到 23.8 億美元，到 2026 年將成長至 25.9 億美元，到 2032 年將達到 42.5 億美元，複合年成長率為 8.62%。

主要市場統計數據
基準年 2025 23.8億美元
預計年份：2026年 25.9億美元
預測年份 2032 42.5億美元
複合年成長率 (%) 8.62%

簡要概述十二指腸內視鏡的臨床作用、再處理方面的挑戰、感染控制的重要性、技術進步以及影響近期器材策略的相關人員趨勢。

十二指腸鏡在高級內視鏡手術中發揮著至關重要的作用，它能夠實現諸如內視鏡逆行造影（ERCP）等診斷和治療技術，而ERCP對於膽道和胰腺疾病的診治至關重要。其複雜的結構設計（可實現通道式入路、成像和器械輸送）是其臨床效用的基礎，但也帶來了再處理方面的複雜性以及醫療設備相關感染的風險。近年來，引人注目的感染病例和日益嚴格的監管審查，使得人們對這種醫療設備的關注點從單純的臨床應用轉向了病患安全措施、籌資策略和生產品質保證等方面。

對重塑十二指腸內視鏡市場的變革性變化進行前瞻性概述，包括一次性產品的引入、設計創新、監管壓力和供應鏈重組。

十二指腸內視鏡市場正經歷著結構性變革時期，其驅動力來自臨床安全要求、技術創新以及採購行為的轉變。一次性內視鏡的普及正成為一股顛覆性力量，這主要得益於醫療機構對感染控制和工作流程效率的日益重視。同時，可重複使用內視鏡的製造商也在加速改進設備設計、材料以及與先進再處理技術的兼容性，以應對滅菌方面的挑戰，同時保持可重複使用平台的臨床優勢。

對美國已實施和提案於 2025 年實施的關稅措施如何改變供應鏈經濟、貨源選擇、製造地和採購行為進行重點分析。

美國2025年的關稅決定引入了新的貿易動態，將對十二指腸內視鏡及相關耗材的採購、供應商選擇和製造地選擇產生重大影響。關稅調整將影響整個複雜價值鏈的成本結構，而精密製造、光學技術和特殊聚合物等零件通常依賴國際採購。對於採購者而言，直接影響是多方面的。採購團隊必須重新評估其對供應商總到岸成本的假設，評估替代採購區域的可行性，並考慮重新談判的供應合約對其營運的影響。

精細的細分洞察揭示了產品類型、最終用戶、臨床應用和分銷管道如何對採用、購買和營運實踐產生不同的影響。

有效的市場區隔能清楚展現十二指腸內視鏡市場整體中，市場接受度壓力與商業性機會的差異所在。依產品類型，市場可分為「可重複使用」與「一次性」兩大類，其中「可重複使用」類又可細分為「傳統型」和「增強型」設計，後者俱備便於再處理和提升診斷能力的特性。這些差異顯著影響了採購決策。一次性產品強調降低感染風險和簡化物流，而傳統型可重複使用產品則著重於單次手術成本和長期使用壽命，增強型可重複使用產品圖在這些優先事項的基礎上，進一步提升安全性。

美洲、歐洲、中東和非洲以及亞太地區的區域策略趨勢和臨床應用差異正在影響商業性和監管策略。

醫療設備偏好、監管嚴格程度和採購方式的地理分佈在不同主要地區存在顯著差異，從而導致不同的策略應對措施。在美洲，採購往往集中在大規模醫療系統內部，並受到嚴格的感染控制標準的驅動。這推動了對檢驗的再處理解決方案以及高風險環境下的替代性一次性使用方案的需求。支付和報銷機制也會影響各機構如何權衡對再處理基礎設施的投資與採用一次性醫療設備之間的關係。

對領先的醫療設備製造商、服務供應商和經銷商如何調整產品系列、夥伴關係和品管系統以確保韌性進行競爭考察和企業趨勢洞察。

領先的製造商和服務供應商正從單一產品策略轉向整合解決方案，將醫療設備的效能與檢驗處理、培訓和資訊服務相結合。許多公司正在投資進行設計改進，優先考慮可清洗性和與自動化再處理系統的兼容性，同時也在開發配件生態系統和數位化解決方案，以增強可追溯性和用戶回饋。醫療設備製造商與滅菌服務供應商和經銷商之間的合作日益普遍，從而能夠提供捆綁式提案，簡化採購流程並降低組織風險。

為製造商、醫療保健提供者和通路合作夥伴提供可操作且優先考慮的建議，以降低風險、最佳化營運並加速採用安全技術。

產業領導者應優先採取一系列策略干預措施，以降低臨床風險並增強商業性韌性。首先，他們應投資於設計和工程改進，以顯著提高產品的可清洗性和與自動化再處理系統的兼容性，同時確保配件的兼容性，從而維持臨床功能。其次，他們應重組供應鏈策略，以降低關稅衝擊和零件短缺的風險。這包括選擇替代供應商、評估關鍵部件的部分在地採購，以及提高與一級和二級供應商關係的透明度。

本報告詳細介紹了高度透明的調查方法，包括初步調查、專家檢驗、醫療設備和監管審查，以及用於得出可靠的定性結果的三角測量方法。

本執行摘要所依據的研究整合了初步訪談、醫療設備技術審查和監管文件分析，建構了一個多方面的證據基礎。初步研究包括對臨床終端使用者、採購經理、滅菌專家和醫療設備工程師的詳細訪談，以了解實際操作、流程限制和採購因素。這些定性研究結果與對醫療設備結構、再處理通訊協定以及已報告的召回和安全資訊的技術評估進行了交叉比對，以確保臨床實踐與醫療設備的性能特徵相符。

最後，本文將重點介紹如何協調臨床安全要求與商業策略以及整個生態系統中持續的技術變革，從而實現實際應用。

總而言之，十二指腸內視鏡生態系統正面臨著病患安全需求、技術創新、監管預期和不斷變化的商業性經濟等諸多複雜挑戰。將醫療設備的選擇和供應合約視為綜合性的臨床和營運決策的相關人員，將更有能力在維持手術能力的同時管理風險。可重複使用設計改進和一次性替代方案這兩種路徑，都體現了生命週期成本、環境因素和感染預防之間合理的權衡，並且都需要嚴謹的證據和運營的一致性才能取得成功。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 十二指腸內視鏡市場：依產品類型分類

  • 可重複使用的
    • 傳統的
    • 增強型
  • 一次性的

第9章 十二指腸內視鏡市場：依通路分類

  • 直接地
  • 間接
    • 批發商
    • 零售商

第10章 十二指腸內視鏡市場：依最終用戶分類

  • 門診手術中心
  • 診所
  • 醫院

第11章 十二指腸內視鏡市場：依應用領域分類

  • 診斷
  • 治療

第12章 十二指腸內視鏡市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章 十二指腸內視鏡市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 十二指腸內視鏡市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國十二指腸內視鏡市場

第16章：中國十二指腸內視鏡市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Ambu A/S
  • B. Braun Melsungen AG
  • Boston Scientific Corporation
  • Cantel Medical Corporation
  • CONMED Corporation
  • Cook Medical
  • EndoChoice, Inc.
  • Erbe Elektromedizin GmbH
  • FUJIFILM Holdings Corporation
  • Getinge AB
  • HOYA Corporation
  • Intuitive Surgical, Inc.
  • Johnson & Johnson Services, Inc.
  • KARL STORZ SE & Co. KG
  • Medtronic plc
  • Olympus Corporation
  • Ottomed Endoscopy
  • Richard Wolf GmbH
  • Smith & Nephew plc
  • SonoScape Medical Corp.
  • STERIS plc
  • Stryker Corporation
  • Teleflex Incorporated
Product Code: MRR-C002B1C99487

The Duodenoscopes Market was valued at USD 2.38 billion in 2025 and is projected to grow to USD 2.59 billion in 2026, with a CAGR of 8.62%, reaching USD 4.25 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 2.38 billion
Estimated Year [2026] USD 2.59 billion
Forecast Year [2032] USD 4.25 billion
CAGR (%) 8.62%

A concise orientation to duodenoscope clinical role, reprocessing challenges, infection control imperatives, technological evolution, and stakeholder dynamics shaping near-term device strategies

Duodenoscopes occupy a critical role in advanced endoscopy, enabling diagnostic and therapeutic procedures such as endoscopic retrograde cholangiopancreatography (ERCP) that are essential for biliary and pancreatic disease management. Their intricate design, which permits channelized access, imaging, and instrument delivery, underpins clinical utility but simultaneously creates reprocessing complexity and vulnerability to device-associated infections. Over recent years, high-profile infection events and enhanced regulatory scrutiny have elevated the device from a purely clinical asset to a focal point for patient safety initiatives, procurement strategy, and manufacturing quality assurance.

Consequently, stakeholders across clinical, regulatory, and commercial functions are recalibrating priorities. Infection prevention teams demand demonstrable reprocessing validation and traceability, procurement organizations seek total cost and risk transparency, and device manufacturers respond with engineering changes, reprocessing adjuncts, and alternative product models. As a result, the duodenoscope landscape is being reshaped by competing imperatives: maximizing clinical capability while minimizing cross-contamination risk and operational friction. This executive summary synthesizes these dynamics to inform strategic decision making for providers, manufacturers, and channel partners operating in this technically demanding segment.

A forward-looking synthesis of transformative shifts reshaping the duodenoscope landscape including single-use adoption, design innovation, regulatory pressure, and supply chain reconfiguration

The duodenoscope market is experiencing a period of structural transformation driven by a convergence of clinical safety demands, engineering innovation, and shifting procurement behaviors. Single-use device adoption has emerged as a disruptive force, spurred by institutions prioritizing infection avoidance and streamlined workflow. At the same time, manufacturers of reusable scopes are accelerating enhancements in device design, materials, and compatibility with advanced reprocessing technologies to preserve the clinical advantages of reusable platforms while addressing sterilization gaps.

Regulatory agencies and hospital accreditation bodies have tightened expectations for validation, surveillance, and reporting, prompting more rigorous clinical surveillance programs and tighter procurement specifications. Simultaneously, digitalization-ranging from embedded diagnostics to cloud-enabled reprocessing logs-is changing how devices are monitored and how value is communicated to buyers. Supply chain resilience has become a strategic concern, with nearshoring and diversified sourcing increasingly considered to mitigate disruption risk. Together, these shifts are not incremental; they represent a redefinition of acceptable tradeoffs between cost, clinical performance, and patient safety, compelling all ecosystem participants to adopt more transparent, evidence-based approaches to product development and commercialization.

A focused analysis of how recent and proposed United States tariff measures in 2025 are altering supply economics, sourcing choices, manufacturing footprints, and procurement behavior

United States tariff decisions in 2025 introduced new trade dynamics that materially influence procurement, sourcing, and manufacturing choices for duodenoscopes and associated consumables. Tariff adjustments affect cost structures across complex value chains where precision manufacturing, optics, and specialized polymers are often sourced internationally. For buyers, the immediate implications are layered: procurement teams must reassess supplier total landed cost assumptions, evaluate the viability of alternative sourcing geographies, and consider the operational impact of re-negotiated supply agreements.

Manufacturers confronted with higher input costs are reviewing production footprints and may accelerate strategies that reduce exposure to tariff volatility, including component localization, qualification of domestic sub-suppliers, or vertical integration for critical subsystems. These strategic shifts also influence channel economics, as distributors and service providers reconsider inventory strategies and lead times. Regulatory considerations intersect with tariff impacts because changes to manufacturing locations or suppliers frequently necessitate additional validation and documentation. In this environment, stakeholders who proactively map supply dependencies, test alternative sourcing scenarios, and engage in collaborative contracting are better positioned to maintain continuity of care and protect margins without compromising compliance or clinical performance.

Granular segmentation insights revealing how product types, end users, clinical applications, and distribution channels differentially influence adoption, purchasing, and operational practices

Meaningful segmentation clarifies where adoption pressures and commercial opportunities diverge across the duodenoscope landscape. Based on product type, the market is studied across Reusable and Single-Use, with the Reusable category further differentiated into Conventional and Enhanced designs that incorporate reprocessing-friendly features or diagnostic upgrades. These variations drive distinct procurement conversations: single-use models emphasize infection risk mitigation and simplified logistics, whereas conventional reusable products focus on per-procedure economics and long lifecycle performance, and enhanced reusable models attempt to balance those priorities with improved safety features.

Based on end user, the market is studied across Ambulatory Surgical Centers, Clinics, and Hospitals, each with different procedural volumes, sterilization capabilities, and capital allocation constraints that influence device selection and service model preferences. Based on application, the market is studied across Diagnostic and Therapeutic indications, where the need for accessory compatibility, imaging resolution, and torque response can favor particular device formats. Based on distribution channel, the market is studied across Direct and Indirect pathways, with the Indirect route further segmented into Distributor and Retailer relationships that affect inventory strategies, service bundling, and post-sale support. Understanding these intersecting segmentations is essential to tailor product design, pricing, and customer engagement models that align with the operational realities of each buyer cohort.

Regional strategic patterns and clinical adoption differentials across Americas, Europe, Middle East & Africa, and Asia-Pacific that inform commercial and regulatory tactics

Geographic patterns in device preference, regulatory intensity, and procurement modality vary substantially across major regions, shaping distinct strategic responses. In the Americas, procurement tends to be centralized within large health systems and driven by stringent infection control standards, which increases demand for validated reprocessing solutions and alternative single-use options in high-risk settings. Payment and reimbursement mechanisms also influence how organizations weigh capital investment in reprocessing infrastructure against disposable device adoption.

In Europe, Middle East & Africa, heterogeneity in regulatory frameworks and healthcare financing creates a mosaic of adoption behaviors, where higher-resource markets emphasize validated reprocessing and traceability, while other jurisdictions prioritize cost containment and supply availability. Regulatory harmonization efforts and cross-border collaboration are influencing product registration and post-market surveillance approaches. In Asia-Pacific, rapid procedural growth, rising clinical capacity, and diverse manufacturing ecosystems produce both strong demand for cost-effective reusable instruments and opportunities for locally produced single-use alternatives. Regional supply chain strategies, local manufacturing partnerships, and regulatory engagement are therefore critical levers for commercial success across these differentiated markets.

Competitive and corporate insights on how leading device makers, service providers, and distributors are aligning product portfolios, partnerships, and quality systems for resilience

Leading manufacturers and service providers are shifting from single-product strategies toward integrated solutions that combine device performance with validated reprocessing, training, and data services. Many corporations are investing in design changes that prioritize cleanability and compatibility with automated reprocessing equipment while also developing accessory ecosystems and digital offerings that enhance traceability and user feedback. Partnerships between device firms and sterilization service providers or distributors are increasingly common, enabling bundled propositions that simplify procurement and reduce institutional risk.

Commercial differentiation is also emerging through warranty and service models that share risk with customers, such as outcome-linked agreements or comprehensive managed service contracts. Firms that excel in regulatory intelligence, post-market surveillance, and rapid corrective action gain credibility with large health systems that demand transparent evidence of safety and efficacy. Meanwhile, smaller innovators and start-ups are concentrating on niche opportunities, including lower-cost single-use devices or advanced imaging modules, forcing incumbents to balance core portfolio defense with targeted acquisitions or licensing arrangements. Across the ecosystem, the ability to demonstrate validated processes, supply resilience, and measurable clinical benefit is becoming the primary axis of competitive advantage.

Practical, prioritized recommendations for manufacturers, healthcare providers, and channel partners to mitigate risk, optimize operations, and accelerate safe technology adoption

Industry leaders should prioritize a set of strategic interventions that reduce clinical risk and reinforce commercial resilience. First, invest in design and engineering improvements that materially enhance cleanability and compatibility with automated reprocessing systems, while ensuring accessory compatibility to preserve clinical capability. Second, reconfigure supply chain strategies to reduce exposure to tariff shocks and component scarcity; this includes qualifying alternative suppliers, evaluating partial localization for critical components, and increasing transparency in supplier tier-one and tier-two relationships.

Third, adopt outcome-oriented commercial models that align incentives with health system goals, such as managed service contracts that bundle device performance, maintenance, and reprocessing oversight. Fourth, strengthen regulatory and post-market capabilities to accelerate response to safety signals and provide customers with robust evidence packages. Finally, develop targeted engagement programs for distinct buyer segments-ambulatory centers, clinics, and hospitals-tailoring value propositions to procedural volume, sterilization capability, and capital constraints. Implementing these recommendations will require cross-functional coordination but will materially reduce operational risk and create differentiated customer value.

Transparent research methodology detailing primary engagement, expert validation, device and regulatory review, and triangulation methods used to produce robust qualitative insights

The research underpinning this executive summary integrates primary interviews, device technical reviews, and regulatory documentation analysis to construct a multi-source evidence base. Primary engagements included in-depth interviews with clinical end users, procurement leaders, sterilization specialists, and device engineers to capture operational realities, procedural constraints, and procurement drivers. These qualitative insights were triangulated with technical assessments of device construction, reprocessing protocols, and reported device recalls or safety communications to ensure alignment between clinical practice and device performance characteristics.

Regulatory and standards databases were reviewed to map evolving compliance expectations and surveillance requirements. Additionally, supply chain mapping exercises identified key supplier dependencies and potential bottlenecks. Throughout the process, expert validation occurred via panels of clinicians, infection preventionists, and industry practitioners to vet findings and refine practical recommendations. This mixed-methods approach emphasizes reproducibility, transparency, and direct relevance to decision makers seeking evidence-based pathways for procurement, product development, and operational improvement.

Conclusive synthesis emphasizing actionable takeaways that reconcile clinical safety imperatives with commercial strategy and ongoing technology transitions across the ecosystem

In synthesis, the duodenoscope ecosystem is navigating a complex intersection of patient safety imperatives, engineering innovation, regulatory expectations, and shifting commercial economics. Stakeholders who treat device selection and supply contracting as integrated clinical-operational decisions will be better positioned to manage risk while preserving procedural capability. The dual trajectories of enhanced reusable designs and single-use alternatives reflect legitimate tradeoffs between lifecycle cost, environmental considerations, and infection prevention, and both paths require rigorous evidence and operational alignment to succeed.

Strategic responses that combine design improvement, supply chain diversification, and outcome-oriented commercial models provide a pragmatic route to reconciling clinical needs with organizational constraints. Ultimately, the most resilient actors will be those that transparently document performance, maintain agile sourcing strategies, and partner closely with clinical teams to ensure that device choices support both patient safety and sustainable operational models. This report equips decision makers with the contextualized insights needed to navigate these tradeoffs and to implement practical steps that reduce risk and enhance value.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Duodenoscopes Market, by Product Type

  • 8.1. Reusable
    • 8.1.1. Conventional
    • 8.1.2. Enhanced
  • 8.2. Single-Use

9. Duodenoscopes Market, by Distribution Channel

  • 9.1. Direct
  • 9.2. Indirect
    • 9.2.1. Distributor
    • 9.2.2. Retailer

10. Duodenoscopes Market, by End User

  • 10.1. Ambulatory Surgical Centers
  • 10.2. Clinics
  • 10.3. Hospitals

11. Duodenoscopes Market, by Application

  • 11.1. Diagnostic
  • 11.2. Therapeutic

12. Duodenoscopes Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Duodenoscopes Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Duodenoscopes Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Duodenoscopes Market

16. China Duodenoscopes Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Ambu A/S
  • 17.6. B. Braun Melsungen AG
  • 17.7. Boston Scientific Corporation
  • 17.8. Cantel Medical Corporation
  • 17.9. CONMED Corporation
  • 17.10. Cook Medical
  • 17.11. EndoChoice, Inc.
  • 17.12. Erbe Elektromedizin GmbH
  • 17.13. FUJIFILM Holdings Corporation
  • 17.14. Getinge AB
  • 17.15. HOYA Corporation
  • 17.16. Intuitive Surgical, Inc.
  • 17.17. Johnson & Johnson Services, Inc.
  • 17.18. KARL STORZ SE & Co. KG
  • 17.19. Medtronic plc
  • 17.20. Olympus Corporation
  • 17.21. Ottomed Endoscopy
  • 17.22. Richard Wolf GmbH
  • 17.23. Smith & Nephew plc
  • 17.24. SonoScape Medical Corp.
  • 17.25. STERIS plc
  • 17.26. Stryker Corporation
  • 17.27. Teleflex Incorporated

LIST OF FIGURES

  • FIGURE 1. GLOBAL DUODENOSCOPES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL DUODENOSCOPES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL DUODENOSCOPES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL DUODENOSCOPES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL DUODENOSCOPES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL DUODENOSCOPES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL DUODENOSCOPES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL DUODENOSCOPES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL DUODENOSCOPES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL DUODENOSCOPES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES DUODENOSCOPES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA DUODENOSCOPES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL DUODENOSCOPES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL DUODENOSCOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL DUODENOSCOPES MARKET SIZE, BY REUSABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL DUODENOSCOPES MARKET SIZE, BY REUSABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL DUODENOSCOPES MARKET SIZE, BY REUSABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL DUODENOSCOPES MARKET SIZE, BY REUSABLE, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL DUODENOSCOPES MARKET SIZE, BY CONVENTIONAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL DUODENOSCOPES MARKET SIZE, BY CONVENTIONAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL DUODENOSCOPES MARKET SIZE, BY CONVENTIONAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL DUODENOSCOPES MARKET SIZE, BY ENHANCED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL DUODENOSCOPES MARKET SIZE, BY ENHANCED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL DUODENOSCOPES MARKET SIZE, BY ENHANCED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL DUODENOSCOPES MARKET SIZE, BY SINGLE-USE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL DUODENOSCOPES MARKET SIZE, BY SINGLE-USE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL DUODENOSCOPES MARKET SIZE, BY SINGLE-USE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL DUODENOSCOPES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL DUODENOSCOPES MARKET SIZE, BY DIRECT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL DUODENOSCOPES MARKET SIZE, BY DIRECT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL DUODENOSCOPES MARKET SIZE, BY DIRECT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL DUODENOSCOPES MARKET SIZE, BY INDIRECT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL DUODENOSCOPES MARKET SIZE, BY INDIRECT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL DUODENOSCOPES MARKET SIZE, BY INDIRECT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL DUODENOSCOPES MARKET SIZE, BY INDIRECT, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL DUODENOSCOPES MARKET SIZE, BY DISTRIBUTOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL DUODENOSCOPES MARKET SIZE, BY DISTRIBUTOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL DUODENOSCOPES MARKET SIZE, BY DISTRIBUTOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL DUODENOSCOPES MARKET SIZE, BY RETAILER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL DUODENOSCOPES MARKET SIZE, BY RETAILER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL DUODENOSCOPES MARKET SIZE, BY RETAILER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL DUODENOSCOPES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL DUODENOSCOPES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL DUODENOSCOPES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL DUODENOSCOPES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL DUODENOSCOPES MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL DUODENOSCOPES MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL DUODENOSCOPES MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL DUODENOSCOPES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL DUODENOSCOPES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL DUODENOSCOPES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL DUODENOSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL DUODENOSCOPES MARKET SIZE, BY DIAGNOSTIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL DUODENOSCOPES MARKET SIZE, BY DIAGNOSTIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL DUODENOSCOPES MARKET SIZE, BY DIAGNOSTIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL DUODENOSCOPES MARKET SIZE, BY THERAPEUTIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL DUODENOSCOPES MARKET SIZE, BY THERAPEUTIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL DUODENOSCOPES MARKET SIZE, BY THERAPEUTIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL DUODENOSCOPES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. AMERICAS DUODENOSCOPES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 49. AMERICAS DUODENOSCOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 50. AMERICAS DUODENOSCOPES MARKET SIZE, BY REUSABLE, 2018-2032 (USD MILLION)
  • TABLE 51. AMERICAS DUODENOSCOPES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 52. AMERICAS DUODENOSCOPES MARKET SIZE, BY INDIRECT, 2018-2032 (USD MILLION)
  • TABLE 53. AMERICAS DUODENOSCOPES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 54. AMERICAS DUODENOSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 55. NORTH AMERICA DUODENOSCOPES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. NORTH AMERICA DUODENOSCOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 57. NORTH AMERICA DUODENOSCOPES MARKET SIZE, BY REUSABLE, 2018-2032 (USD MILLION)
  • TABLE 58. NORTH AMERICA DUODENOSCOPES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 59. NORTH AMERICA DUODENOSCOPES MARKET SIZE, BY INDIRECT, 2018-2032 (USD MILLION)
  • TABLE 60. NORTH AMERICA DUODENOSCOPES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 61. NORTH AMERICA DUODENOSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 62. LATIN AMERICA DUODENOSCOPES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. LATIN AMERICA DUODENOSCOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 64. LATIN AMERICA DUODENOSCOPES MARKET SIZE, BY REUSABLE, 2018-2032 (USD MILLION)
  • TABLE 65. LATIN AMERICA DUODENOSCOPES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 66. LATIN AMERICA DUODENOSCOPES MARKET SIZE, BY INDIRECT, 2018-2032 (USD MILLION)
  • TABLE 67. LATIN AMERICA DUODENOSCOPES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 68. LATIN AMERICA DUODENOSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 69. EUROPE, MIDDLE EAST & AFRICA DUODENOSCOPES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 70. EUROPE, MIDDLE EAST & AFRICA DUODENOSCOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 71. EUROPE, MIDDLE EAST & AFRICA DUODENOSCOPES MARKET SIZE, BY REUSABLE, 2018-2032 (USD MILLION)
  • TABLE 72. EUROPE, MIDDLE EAST & AFRICA DUODENOSCOPES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 73. EUROPE, MIDDLE EAST & AFRICA DUODENOSCOPES MARKET SIZE, BY INDIRECT, 2018-2032 (USD MILLION)
  • TABLE 74. EUROPE, MIDDLE EAST & AFRICA DUODENOSCOPES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 75. EUROPE, MIDDLE EAST & AFRICA DUODENOSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 76. EUROPE DUODENOSCOPES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. EUROPE DUODENOSCOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 78. EUROPE DUODENOSCOPES MARKET SIZE, BY REUSABLE, 2018-2032 (USD MILLION)
  • TABLE 79. EUROPE DUODENOSCOPES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 80. EUROPE DUODENOSCOPES MARKET SIZE, BY INDIRECT, 2018-2032 (USD MILLION)
  • TABLE 81. EUROPE DUODENOSCOPES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 82. EUROPE DUODENOSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 83. MIDDLE EAST DUODENOSCOPES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. MIDDLE EAST DUODENOSCOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 85. MIDDLE EAST DUODENOSCOPES MARKET SIZE, BY REUSABLE, 2018-2032 (USD MILLION)
  • TABLE 86. MIDDLE EAST DUODENOSCOPES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 87. MIDDLE EAST DUODENOSCOPES MARKET SIZE, BY INDIRECT, 2018-2032 (USD MILLION)
  • TABLE 88. MIDDLE EAST DUODENOSCOPES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 89. MIDDLE EAST DUODENOSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 90. AFRICA DUODENOSCOPES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. AFRICA DUODENOSCOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 92. AFRICA DUODENOSCOPES MARKET SIZE, BY REUSABLE, 2018-2032 (USD MILLION)
  • TABLE 93. AFRICA DUODENOSCOPES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 94. AFRICA DUODENOSCOPES MARKET SIZE, BY INDIRECT, 2018-2032 (USD MILLION)
  • TABLE 95. AFRICA DUODENOSCOPES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 96. AFRICA DUODENOSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 97. ASIA-PACIFIC DUODENOSCOPES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. ASIA-PACIFIC DUODENOSCOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 99. ASIA-PACIFIC DUODENOSCOPES MARKET SIZE, BY REUSABLE, 2018-2032 (USD MILLION)
  • TABLE 100. ASIA-PACIFIC DUODENOSCOPES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 101. ASIA-PACIFIC DUODENOSCOPES MARKET SIZE, BY INDIRECT, 2018-2032 (USD MILLION)
  • TABLE 102. ASIA-PACIFIC DUODENOSCOPES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC DUODENOSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL DUODENOSCOPES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. ASEAN DUODENOSCOPES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. ASEAN DUODENOSCOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 107. ASEAN DUODENOSCOPES MARKET SIZE, BY REUSABLE, 2018-2032 (USD MILLION)
  • TABLE 108. ASEAN DUODENOSCOPES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 109. ASEAN DUODENOSCOPES MARKET SIZE, BY INDIRECT, 2018-2032 (USD MILLION)
  • TABLE 110. ASEAN DUODENOSCOPES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 111. ASEAN DUODENOSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 112. GCC DUODENOSCOPES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. GCC DUODENOSCOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 114. GCC DUODENOSCOPES MARKET SIZE, BY REUSABLE, 2018-2032 (USD MILLION)
  • TABLE 115. GCC DUODENOSCOPES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 116. GCC DUODENOSCOPES MARKET SIZE, BY INDIRECT, 2018-2032 (USD MILLION)
  • TABLE 117. GCC DUODENOSCOPES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 118. GCC DUODENOSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPEAN UNION DUODENOSCOPES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPEAN UNION DUODENOSCOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPEAN UNION DUODENOSCOPES MARKET SIZE, BY REUSABLE, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPEAN UNION DUODENOSCOPES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPEAN UNION DUODENOSCOPES MARKET SIZE, BY INDIRECT, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPEAN UNION DUODENOSCOPES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPEAN UNION DUODENOSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 126. BRICS DUODENOSCOPES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. BRICS DUODENOSCOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. BRICS DUODENOSCOPES MARKET SIZE, BY REUSABLE, 2018-2032 (USD MILLION)
  • TABLE 129. BRICS DUODENOSCOPES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 130. BRICS DUODENOSCOPES MARKET SIZE, BY INDIRECT, 2018-2032 (USD MILLION)
  • TABLE 131. BRICS DUODENOSCOPES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 132. BRICS DUODENOSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 133. G7 DUODENOSCOPES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 134. G7 DUODENOSCOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 135. G7 DUODENOSCOPES MARKET SIZE, BY REUSABLE, 2018-2032 (USD MILLION)
  • TABLE 136. G7 DUODENOSCOPES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 137. G7 DUODENOSCOPES MARKET SIZE, BY INDIRECT, 2018-2032 (USD MILLION)
  • TABLE 138. G7 DUODENOSCOPES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 139. G7 DUODENOSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 140. NATO DUODENOSCOPES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 141. NATO DUODENOSCOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. NATO DUODENOSCOPES MARKET SIZE, BY REUSABLE, 2018-2032 (USD MILLION)
  • TABLE 143. NATO DUODENOSCOPES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 144. NATO DUODENOSCOPES MARKET SIZE, BY INDIRECT, 2018-2032 (USD MILLION)
  • TABLE 145. NATO DUODENOSCOPES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 146. NATO DUODENOSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 147. GLOBAL DUODENOSCOPES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 148. UNITED STATES DUODENOSCOPES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 149. UNITED STATES DUODENOSCOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 150. UNITED STATES DUODENOSCOPES MARKET SIZE, BY REUSABLE, 2018-2032 (USD MILLION)
  • TABLE 151. UNITED STATES DUODENOSCOPES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 152. UNITED STATES DUODENOSCOPES MARKET SIZE, BY INDIRECT, 2018-2032 (USD MILLION)
  • TABLE 153. UNITED STATES DUODENOSCOPES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 154. UNITED STATES DUODENOSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 155. CHINA DUODENOSCOPES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 156. CHINA DUODENOSCOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. CHINA DUODENOSCOPES MARKET SIZE, BY REUSABLE, 2018-2032 (USD MILLION)
  • TABLE 158. CHINA DUODENOSCOPES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 159. CHINA DUODENOSCOPES MARKET SIZE, BY INDIRECT, 2018-2032 (USD MILLION)
  • TABLE 160. CHINA DUODENOSCOPES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 161. CHINA DUODENOSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)